Isomorphic Labs: Demis Hassabis’s AI drug-discovery startup raises $5B
Isomorphic Labs, Demis Hassabis’s AI drug-discovery startup, has raised $5 billion to scale its IsoDDE platform and move AI-generated drug candidates into later clinical stages.
Isomorphic Labs, the AI drug-discovery startup led by Demis Hassabis, has raised $5 billion in investment.
Formally, it is an Alphabet subsidiary; in practice, it is a DeepMind spin-off guided by Hassabis. Isomorphic Labs’ mission is stated as “Solve All Disease.”
This round included major investors such as Andreessen Horowitz, Greenoaks, and Sequoia Capital, among others. With the $5 billion, Isomorphic Labs plans to scale its proprietary drug-design engine IsoDDE and advance AI-generated drug candidates to the next clinical trial stages and eventually to market.
According to Isomorphic Labs, the goal is to begin a new era of biomedical breakthroughs and give patients next-generation medicines.
Why it matters
AnalysisThis is one of the largest funding rounds in AI-driven biomedicine and a signal that AI drug discovery is moving from research pilots to industrial scale. If IsoDDE succeeds, it could accelerate new therapies while intensifying regulatory, ethical and safety scrutiny of AI in medicine.
Discuss in community
Share your questions and insights with developers
Related in Ecosystem
Practical guides, core terminology, and agent skills
We understand Hugging Face and transformers: from startup to architectures
A step-by-step guide for those who want to understand how modern language models (BERT, GPT and others) work, how to run them, use them and adapt them to their tasks - using the example of the Transformers library and the Hugging Face platform.
ElevenLabs Updates: Comprehensive Guide to New Tools and Voice Control
Comprehensive guide to ElevenLabs speech generation: model overview (v3, Multilingual v2, Flash, Turbo), emotional audio tags, IPA/Arpabet phonemes, PLS dictionaries, and text normalization.
ElevenLabs (Global Leader in Generative Audio and Voice)
Leading technology platform for text-to-speech (TTS) and voice AI. Transforms text into live emotional human speech, clones voices, and automatically dubs videos in 30+ languages.
Agent-to-Agent Protocol (A2A)
An open standard for network interaction, decentralized discovery, and secure context exchange between independent AI agents across various vendors and platforms.